Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire and IBM Partner to Link Software With Middleware; Sign Aventis as First Buyer


IBM and Spotfire have agreed to combine Spotfire’s software with IBM’s back-end information management, data integration, and computing infrastructure, and have already found their first customer for the united technology in Aventis.

Under the alliance, Spotfire will optimize its DecisionSite application platform — as well as other current and future e-analytic applications — for IBM platforms and middleware, including its DB2 database and DiscoveryLink.

In addition, IBM will co-market Spotfire as a preferred e-analytic application for its life sciences customers and Spotfire will co-market DiscoveryLink for data integration.

Aventis said it would use DiscoveryLink to manage and integrate data from multiple biological and chemical databases and will use DecisionSite to allow its researchers to query those databases and identify new drug targets. The company said it expects this combination of techniques to reduce its drug innovation and approval time from 10-15 years to 6-9 years.

David Butler, vice president of product strategy and marketing at Spotfire, said the decision to partner with IBM was spurred by its customers. “We’ve already got a number of users at Aventis and they were saying, ‘Let’s bring these two platforms together so we can standardize on one just approach on the desktop to data integration.’”

Butler added that companies such as Aventis, who are looking to merge functional genomics data with information derived from cheminformatics, bioinformatics, and other sources, are just beginning to question their data integration capabilities.

Butler said it made sense for Spotfire to address this emerging trend by partnering with a provider of integration technology rather than tackle the problem in its own.

Likewise, Sharon Nunes, director of life sciences solutions at IBM, said DiscoveryLink is of value “only if we have a really good interface for the end user.” The partnership with Spotfire provides an accessible front end, she said, “because people don’t want to read this vast amount of data in tables.”

Both IBM and Spotfire are involved in similar partnerships to integrate their products with those of other vendors. IBM is integrating DiscoveryLink with products from Micromass, LabBook, and NetGenics, while Spotfire is integrating DecisionSite with products from Micromass and Celera.

“We’re really looking at providing multiple solutions because I think the end users never settle on one interface,” said Nunes. “Our multiple partnerships let us deliver what we think is a better set of choices for our end user.”

— BT

Filed under

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.